XNAS
SNTI
Market cap10mUSD
Oct 08, Last price
0.32USD
1D
-2.52%
1Q
-68.77%
IPO
-99.68%
Name
Senti Biosciences Inc
Chart & performance
P/E
—
P/S
455.43
EPS
—
Div yield, %
—
Shrs. gr., 5y
119.97%
Rev. gr., 5y
-43.85%
Revenues
22k
Net income
-61m
L+16.38%
CFO
-43m
L+4.94%
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
At present, Dynamics Special Purpose Corp. does not engage in any material business operations. Its sole purpose is to execute a strategic business combination, such as a merger, capital stock exchange, acquisition of assets or stock, or a reorganization, involving one or more existing enterprises. This entity was founded in 2021 and operates from its base in Redwood City, California.
Key people
Kanya Rajangam
President, Head - Research and Development, Chief Medical Officer · since 2024
Timothy Lu
Chief Executive Officer, Director · since 2025
Jay Cross
Chief Financial Officer, Principal Accounting Officer, Principal Financial Officer · since 2025
Bryan Baum
Director · since 2025
Feng Hsiung
Director · since 2025
Frances Schulz
Director · since 2024
Donald Tang
Director
James Collins
Independent Director · since 2022
Brenda Cooperstone
Independent Director · since 2022
Independent Director · since 2022
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | |
| Income | |||||||
Revenues | |||||||
Cost of revenue | |||||||
Unusual Expense (Income) | |||||||
NOPBT | |||||||
NOPBT Margin | |||||||
Operating Taxes | |||||||
Tax Rate | |||||||
NOPAT | |||||||
Net income | |||||||
Dividends | |||||||
Dividend yield | |||||||
Proceeds from repurchase of equity | |||||||
BB yield | |||||||
| Debt | |||||||
Debt current | |||||||
Long-term debt | |||||||
Deferred revenue | |||||||
Other long-term liabilities | |||||||
Net debt | |||||||
| Cash flow | |||||||
Cash from operating activities | |||||||
CAPEX | |||||||
Cash from investing activities | |||||||
Cash from financing activities | |||||||
FCF | |||||||
| Balance | |||||||
Cash | |||||||
Long term investments | |||||||
Excess cash | |||||||
Stockholders' equity | |||||||
Invested Capital | |||||||
ROIC | |||||||
ROCE | |||||||
| EV | |||||||
Common stock shares outstanding | |||||||
Price | |||||||
Market cap | |||||||
EV | |||||||
EBITDA | |||||||
EV/EBITDA | |||||||
Interest | |||||||
Interest/NOPBT | |||||||